Review of electrical stimulation, botulinum toxin, and their combination for spastic drop foot - PowerPoint PPT Presentation

1 / 5
About This Presentation
Title:

Review of electrical stimulation, botulinum toxin, and their combination for spastic drop foot

Description:

Review of electrical stimulation, botulinum toxin, and their combination for spastic drop foot Ari Jacob Levi Wilkenfeld, MD, PhD Aim Review pathophysiology of ... – PowerPoint PPT presentation

Number of Views:50
Avg rating:3.0/5.0
Slides: 6
Provided by: Reb117
Category:

less

Transcript and Presenter's Notes

Title: Review of electrical stimulation, botulinum toxin, and their combination for spastic drop foot


1
Review of electrical stimulation, botulinum
toxin, and their combination for spastic drop
foot
  • Ari Jacob Levi Wilkenfeld, MD, PhD

2
  • Aim
  • Review pathophysiology of spastic drop foot and
    its treatment options.
  • Present theoretical reasons why functional
    electrical stimulation (ES) and botulinum toxin
    (BTX) injections could work synergistically.
  • Relevance
  • There are reasons to think functional ES and BTX
    injections might work effectively in combination,
    but no clear consensus exists in literature.

3
Background
  • Spastic drop foot
  • Weak ankle dorsiflexors and spastic ankle plantar
    flexors predispose ankle to stay pathologically
    plantar flexed.
  • Functional ES
  • Uses electric current to activate muscles and
    nerves that are weak/paralyzed but still have
    intact lower motor neurons and musculature.
  • BTX
  • Prevents acetylcholine release at presynaptic
    terminal, thus impairing neuromuscular
    transmission and inducing weakness.

4
Treatment
  • 4 mechanisms by which ES might increase
    antispasticity effect of BTX.
  • Animal experiments BTXs paralytic effect starts
    earlier when toxin uptake is increased with ES.
  • Moving muscle through flexion/extension cycles
    could help mechanically spread toxin.
  • Direct effects of ES on tone reduction.
  • Simultaneously addressing positive and negative
    components of upper motor neuron syndrome could
    lead to increased functional gains in gait.

5
Conclusions
  • For ES Evidence of decreased spasticity.
  • But, e.g., whether stimulation should be over
    spastic muscle or its antagonist, how long effect
    lasts, and whether it works during gait must be
    clarified.
  • For BTX Evidence of decreased tone.
  • But evidence lacking for improved gait.
  • ESBTX Evidence that ES of muscle may increase
    efficacy of BTX.
  • However, large controlled studies examining
    relative effects are lacking.
Write a Comment
User Comments (0)
About PowerShow.com